Aicuris Anti-Infect
1 products tracked · names used in filings: Aicuris Anti-Infect
Upcoming milestones
No upcoming milestones listed.
Recent milestones
Fri 09 Oct 2026🇺🇸 FDA approval
FDA approves Hovilpri (pritelivir mesylate), a new medicine
Aicuris Anti-Infect; NDA221154; New molecular entity, Priority review; tablet · source
Products
| Product | Status | Approved | |
|---|---|---|---|
| 🇺🇸 | Hovilpri pritelivir mesylate | Approved | 2026-10-09 |
Information from official EMA, FDA, Federal Register and SEC records. Dates marked company-announced come from the company's own SEC filing; dates marked estimate are calculated, not official. Not investment or medical advice; always confirm on the source.